Viewing Study NCT00833105



Ignite Creation Date: 2024-05-05 @ 9:11 PM
Last Modification Date: 2024-10-26 @ 10:00 AM
Study NCT ID: NCT00833105
Status: COMPLETED
Last Update Posted: 2019-05-01
First Post: 2009-01-29

Brief Title: Rehabilitation of the Upper Extremity With Enhanced Proprioceptive Feedback Following Incomplete Spinal Cord Injury
Sponsor: Oregon Health and Science University
Organization: Oregon Health and Science University

Study Overview

Official Title: Rehabilitation of the Upper Extremity With Enhanced Proprioceptive Feedback Following Incomplete Spinal Cord Injury SCI
Status: COMPLETED
Status Verified Date: 2019-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine if tetraplegic individuals with incomplete spinal cord injury SCI who remain unable to move their arms normally 1 year after their SCIs are able to sense and move the affected arms better after 10-13 weeks of treatment with a new robotic therapy device

The hypothesis is that using the AMES device on the arms of chronic tetraplegic subjects with incomplete SCI will result in improved strength sensation and functional movement in treated limbs
Detailed Description: Traumatic spinal cord injury SCI affects over 200000 people in the USA with several thousand new injuries each year Most recovery following SCI occurs in the six months following surgery Further recovery after 12 months is unusual

In this study 13 subjects more than 1 year post injury were enrolled to test the safety and efficacy of a new type of robotic therapy device known as the AMES device The aim of this Phase III study is to investigate the use of assisted movement and enhanced sensation AMES technology in hand rehabilitation of incomplete SCI subjects

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None